|
ZNF434 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.020230E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.954220E-01 |
| Normal-vs-Stage2 |
1.981160E-01 |
| Normal-vs-Stage3 |
5.049600E-04 |
| Normal-vs-Stage4 |
3.478300E-03 |
| Stage1-vs-Stage2 |
6.663600E-01 |
| Stage1-vs-Stage3 |
4.702400E-03 |
| Stage1-vs-Stage4 |
3.300000E-02 |
| Stage2-vs-Stage3 |
1.310790E-01 |
| Stage2-vs-Stage4 |
2.579400E-01 |
| Stage3-vs-Stage4 |
7.532400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.162800E-03 |
| Normal-vs-AfricanAmerican |
9.785600E-01 |
| Normal-vs-Asian |
5.370100E-02 |
| Caucasian-vs-AfricanAmerican |
7.765600E-02 |
| Caucasian-vs-Asian |
1.039760E-02 |
| AfricanAmerican-vs-Asian |
2.150200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.481630E-03 |
| Normal-vs-Female |
3.168000E-01 |
| Male-vs-Female |
1.616430E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.831600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.133900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.392330E-02 |
| Normal-vs-Age(81-100Yrs) |
5.823800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.729600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.940600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.473400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.157400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.571400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.075800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.878600E-01 |
| Normal-vs-Grade 2 |
2.376800E-01 |
| Normal-vs-Grade 3 |
2.345000E-03 |
| Normal-vs-Grade 4 |
1.208650E-04 |
| Grade 1-vs-Grade 2 |
2.477000E-01 |
| Grade 1-vs-Grade 3 |
4.058400E-02 |
| Grade 1-vs-Grade 4 |
6.239900E-03 |
| Grade 2-vs-Grade 3 |
3.120100E-02 |
| Grade 2-vs-Grade 4 |
3.044500E-03 |
| Grade 3-vs-Grade 4 |
1.274180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.882500E-02 |
| Normal-vs-ccB subtype |
1.286970E-01 |
| ccA subtype-vs-ccB subtype |
8.762400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.901550E-02 |
| Normal-vs-N1 |
1.870200E-01 |
| N0-vs-N1 |
5.977800E-01 |
|
|
